Role of oxidative damage and IL-1 beta-converting enzyme-like proteases in Fas-based cytotoxicity exerted by effector T cells

Int Immunol. 1996 Jul;8(7):1173-83. doi: 10.1093/intimm/8.7.1173.

Abstract

The implication of oxidative damage and/or intact mitochondrial function in physiological Fas-based cytotoxicity has been tested using the cytolytic hybridoma d11S and the CD8(+) CTL clone KB5.C20, previously stimulated to express Fas ligand (FasL) on their surface, as effectors and U937 or U937-rho0 cells (depleted of mitochondrial DNA) as targets. Immobilized anti-Fas mAb, which induced death of U937 cells, inhibited the growth of U937-rho0 cells but without inducing cell death. By contrast, FasL-expressing effectors readily killed both targets, with induction of DNA fragmentation, in 20 h assays. These results demonstrate the lack of involvement of mitochondrial-derived free radicals and/or intact mitochondrial function in physiological Fas-based cytotoxicity. Supplementation of Fas-sensitive cells (Jurkat, U937, L1210Fas) with a polyunsaturated fatty acid, which induces cell death through the generation of lipid free radicals, resulted in the potentiation of Fas-based cytotoxicity. This potentiating effect, but not Fas-based cytotoxicity itself, was eliminated by the physiological antioxidant vitamin E. On the other hand, the IL-1beta-converting enzyme (ICE)-like protease tetrapeptide inhibitor Ac-YVAD-cmk partially inhibited Fas-based cytotoxicity, while the specific inhibitor of CPP32/Yama Ac-DEVD-CHO was a much more effective inhibitor of Fas-induced apoptosis. It was concluded that Fas-induced cytotoxicity was clearly dependent on ICE-like protease activation, and especially on that of CPP32 in Fas-sensitive cells, including mitochondrial DNA-depleted ones.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / drug effects
  • Apoptosis / immunology
  • Caspase 1
  • Cysteine Endopeptidases / drug effects
  • Cysteine Endopeptidases / physiology*
  • Cytotoxicity, Immunologic / drug effects*
  • Fatty Acids, Unsaturated / pharmacology
  • Humans
  • L Cells
  • Lymphocyte Activation / drug effects
  • Mice
  • Oxidation-Reduction
  • Oxidative Stress / immunology*
  • Protease Inhibitors / pharmacology
  • T-Lymphocytes, Cytotoxic / drug effects*
  • Tumor Cells, Cultured
  • fas Receptor / drug effects
  • fas Receptor / pharmacology*

Substances

  • Fatty Acids, Unsaturated
  • Protease Inhibitors
  • fas Receptor
  • Cysteine Endopeptidases
  • Caspase 1